We are live on ! Find out more
II

Inspire Investing Portfolio holdings

AUM $2.43B
1-Year Est. Return 49.04%
This Fund
S&P 500
This Quarter Est. Return
+24.71%
1 Year Est. Return
+49.04%
3 Year Est. Return
+108.47%
5 Year Est. Return
+128.46%
10 Year Est. Return
AUM
$2.43B
AUM Growth
+$720M
Cap. Flow
+$434M
Cap. Flow %
17.83%
Top 10 Hldgs %
19.05%
Holding
1,340
New
232
Increased
677
Reduced
261
Closed
74

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$32.6M
2
AVGO icon
Broadcom
AVGO
+$16.2M
3
GEV icon
GE Vernova
GEV
+$14.2M
4
LIN icon
Linde
LIN
+$12.4M
5
NEE icon
NextEra Energy
NEE
+$9.03M

Top Sells

Rank Stock Value
1
PLD icon
Prologis
PLD
+$19.2M
2
NEM icon
Newmont
NEM
+$9.51M
3
FTNT icon
Fortinet
FTNT
+$8.74M
4
QCOM icon
Qualcomm
QCOM
+$6.4M
5
IDCC icon
InterDigital
IDCC
+$6.06M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Industrials 20.23%
3 Financials 9.37%
4 Energy 6.81%
5 Consumer Discretionary 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIRM icon
1201
Mirum Pharmaceuticals
MIRM
$6.15B
$181 ﹤0.01%
2
-2,203
-100% -$221K
PHIN icon
1202
Phinia Inc
PHIN
$2.53B
$165 ﹤0.01%
2
APTV icon
1203
Aptiv
APTV
$9.96B
$161 ﹤0.01%
3
-10
-77% -$612
OLN icon
1204
Olin
OLN
$1.98B
$159 ﹤0.01%
8
TTE icon
1205
TotalEnergies
TTE
$196B
$132 ﹤0.01%
2
ZNTL icon
1206
Zentalis Pharmaceuticals
ZNTL
$378M
$104 ﹤0.01%
21
HRMY icon
1207
Harmony Biosciences
HRMY
$2.46B
$90 ﹤0.01%
2
-4,635
-100% -$146K
CNMD icon
1208
CONMED
CNMD
$1.48B
$87 ﹤0.01%
3
-4
-57% -$144
MGNX icon
1209
MacroGenics
MGNX
$280M
$81 ﹤0.01%
18
EMB icon
1210
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$74 ﹤0.01%
1
MNKD icon
1211
MannKind Corp
MNKD
$1.31B
$69 ﹤0.01%
16
-30,517
-100% -$99.1K
ACGL icon
1212
Arch Capital
ACGL
$33.5B
$65 ﹤0.01%
1
RUM icon
1213
RUM Group Inc
RUM
$4.26B
$63 ﹤0.01%
10
GIL icon
1214
Gildan
GIL
$9.89B
$60 ﹤0.01%
1
JACK icon
1215
Jack in the Box
JACK
$310M
$55 ﹤0.01%
3
-1
-25% -$12
WDS icon
1216
Woodside Energy
WDS
$43.3B
$55 ﹤0.01%
3
-11
-79% -$245
GRAL
1217
GRAIL Inc
GRAL
$3.59B
$51 ﹤0.01%
1
INGN icon
1218
Inogen
INGN
$144M
$48 ﹤0.01%
8
NKTR icon
1219
Nektar Therapeutics
NKTR
$2.53B
$47 ﹤0.01%
1
IOVA icon
1220
Iovance Biotherapeutics
IOVA
$3.98B
$46 ﹤0.01%
11
ACH
1221
Accendra Health
ACH
$93.1M
$44 ﹤0.01%
13
-113
-90% -$351
PK icon
1222
Park Hotels & Resorts
PK
$3.07B
$41 ﹤0.01%
3
PBYI icon
1223
Puma Biotechnology
PBYI
$493M
$39 ﹤0.01%
5
AURA icon
1224
Aura Biosciences
AURA
$784M
$38 ﹤0.01%
5
NTST
1225
NETSTREIT Corp
NTST
$2.04B
$38 ﹤0.01%
2

Similar funds

Inspire Investing's Q2 2026 Portfolio in Review

As of Q2 2026, Inspire Investing held 1,340 positions worth $2.43B, up 42% from $1.71B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Inspire Investing deployed $434M of net new capital in Q2 2026, opening 232 new positions and adding to 677 existing holdings. Its largest new stake was ExxonMobil: 218,045 shares worth $29.8M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Prologis, an estimated $19.2M trimmed.

  • Inspire Investing's largest Q2 2026 buy was ExxonMobil: 218,045 shares worth $29.8M.
  • Inspire Investing added most to Broadcom in Q2 2026, an estimated $16.2M increase.
  • Inspire Investing's biggest Q2 2026 reduction was Prologis, cutting an estimated $19.2M.
  • Inspire Investing fully exited Fortinet in Q2 2026, selling an estimated $8.74M.
  • Inspire Investing's ten largest holdings make up 19% of its $2.43B portfolio in Q2 2026.
  • Inspire Investing opened 232 new positions and closed 74 in Q2 2026.
  • Inspire Investing's portfolio value rose 42% quarter-over-quarter to $2.43B.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.